SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-350418
Filing Date
2018-12-17
Accepted
2018-12-17 07:00:35
Documents
3
Period of Report
2018-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d675629d8k.htm 8-K 21963
2 EX-99.1 d675629dex991.htm EX-99.1 7821
3 GRAPHIC g675629g43a90.gif GRAPHIC 7045
  Complete submission text file 0001193125-18-350418.txt   40882
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 181237000
SIC: 2834 Pharmaceutical Preparations